Yael Mossé, MD, Professor of Pediatrics in the Cancer Center at Children’s Hospital of Philadelphia (CHOP), is a recipient of one of the 2024 Penn Medicine Awards of Excellence. She received the William Osler Patient Oriented Research Award, which was established in 1996 to honor Osler, a “Father of Clinical Medicine” who, in the 1800s, revolutionized clinical teaching and patient-oriented research at the Perelman School of Medicine at the University of Pennsylvania. The Osler Award recognizes achievement for research in which an investigator directly interacts with trial patients.
Mossé is a distinguished physician-scientist whose groundbreaking research on anaplastic lymphoma kinase (ALK) oncogene mutations have transformed the landscape of pediatric oncology, directly enhancing the treatment and outcomes for children with neuroblastoma and other solid tumors. Her work harnessing targeted protein degradation approaches will directly target five essential oncoproteins that drive the growth of childhood solid tumors. As the leader of the Neuroblastoma Developmental Therapeutics Program at CHOP, she fosters collaboration across disciplines to translate genomic discoveries into clinical practice, providing hope and innovative therapies for vulnerable patients from around the world.
The Penn Medicine Awards of Excellence was established in 1996 and is a series of highly competitive awards celebrating Penn Medicine’s commitment to excellence in scholarship, teaching, innovation, service, leadership, professionalism and patient care. Learn more here.
Featured in this article
Specialties & Programs
Yael Mossé, MD, Professor of Pediatrics in the Cancer Center at Children’s Hospital of Philadelphia (CHOP), is a recipient of one of the 2024 Penn Medicine Awards of Excellence. She received the William Osler Patient Oriented Research Award, which was established in 1996 to honor Osler, a “Father of Clinical Medicine” who, in the 1800s, revolutionized clinical teaching and patient-oriented research at the Perelman School of Medicine at the University of Pennsylvania. The Osler Award recognizes achievement for research in which an investigator directly interacts with trial patients.
Mossé is a distinguished physician-scientist whose groundbreaking research on anaplastic lymphoma kinase (ALK) oncogene mutations have transformed the landscape of pediatric oncology, directly enhancing the treatment and outcomes for children with neuroblastoma and other solid tumors. Her work harnessing targeted protein degradation approaches will directly target five essential oncoproteins that drive the growth of childhood solid tumors. As the leader of the Neuroblastoma Developmental Therapeutics Program at CHOP, she fosters collaboration across disciplines to translate genomic discoveries into clinical practice, providing hope and innovative therapies for vulnerable patients from around the world.
The Penn Medicine Awards of Excellence was established in 1996 and is a series of highly competitive awards celebrating Penn Medicine’s commitment to excellence in scholarship, teaching, innovation, service, leadership, professionalism and patient care. Learn more here.
Contact us
Jennifer Lee
Cancer Center